The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Plasma Protein Binding Assay-Global Market Insights and Sales Trends 2025
Synopsis
Plasma Protein Binding Assay is an assay, or an analytic procedure, whose procedure or method relies on the binding of ligand molecules to receptors, antibodies or other macromolecules.[1] A detection method is used to determine the presence and extent of the ligand-receptor complexes formed, and this is usually determined electrochemically or through a fluorescence detection method.[2] This type of analytic test can be used to test for the presence of target molecules in a sample that are known to bind to the receptor.
The global Plasma Protein Binding Assay market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Plasma Protein Binding Assay in various end use industries. The expanding demands from the Pharmaceutical & Biotechnology Companies and Contract Research Organization, are propelling Plasma Protein Binding Assay market. Equillibrium Dialysis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ultrafiltration segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Plasma Protein Binding Assay, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Plasma Protein Binding Assay market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Plasma Protein Binding Assay market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Plasma Protein Binding Assay sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Plasma Protein Binding Assay covered in this report include 3B Pharmaceuticals, Absorption Systems, Admecell, Biotium, Danaher Corporation, Eurofins Scientific, GE Healthcare, Htdialysis and Merck, etc.
The global Plasma Protein Binding Assay market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
3B Pharmaceuticals
Absorption Systems
Admecell
Biotium
Danaher Corporation
Eurofins Scientific
GE Healthcare
Htdialysis
Merck
Sovicell GmbH
Thermo Fisher Scientific
Global Plasma Protein Binding Assay market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Plasma Protein Binding Assay market, Segment by Type:
Equillibrium Dialysis
Ultrafiltration
Ultracentrifugation
Gel Filtration Chromatography
Global Plasma Protein Binding Assay market, by Application
Pharmaceutical & Biotechnology Companies
Contract Research Organization
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Plasma Protein Binding Assay companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Plasma Protein Binding Assay is an assay, or an analytic procedure, whose procedure or method relies on the binding of ligand molecules to receptors, antibodies or other macromolecules.[1] A detection method is used to determine the presence and extent of the ligand-receptor complexes formed, and this is usually determined electrochemically or through a fluorescence detection method.[2] This type of analytic test can be used to test for the presence of target molecules in a sample that are known to bind to the receptor.
The global Plasma Protein Binding Assay market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Plasma Protein Binding Assay in various end use industries. The expanding demands from the Pharmaceutical & Biotechnology Companies and Contract Research Organization, are propelling Plasma Protein Binding Assay market. Equillibrium Dialysis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ultrafiltration segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Plasma Protein Binding Assay, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Plasma Protein Binding Assay market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Plasma Protein Binding Assay market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Plasma Protein Binding Assay sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Plasma Protein Binding Assay covered in this report include 3B Pharmaceuticals, Absorption Systems, Admecell, Biotium, Danaher Corporation, Eurofins Scientific, GE Healthcare, Htdialysis and Merck, etc.
The global Plasma Protein Binding Assay market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
3B Pharmaceuticals
Absorption Systems
Admecell
Biotium
Danaher Corporation
Eurofins Scientific
GE Healthcare
Htdialysis
Merck
Sovicell GmbH
Thermo Fisher Scientific
Global Plasma Protein Binding Assay market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Plasma Protein Binding Assay market, Segment by Type:
Equillibrium Dialysis
Ultrafiltration
Ultracentrifugation
Gel Filtration Chromatography
Global Plasma Protein Binding Assay market, by Application
Pharmaceutical & Biotechnology Companies
Contract Research Organization
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Plasma Protein Binding Assay companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Plasma Protein Binding Assay
1.1 Plasma Protein Binding Assay Market Overview
1.1.1 Plasma Protein Binding Assay Product Scope
1.1.2 Plasma Protein Binding Assay Market Status and Outlook
1.2 Global Plasma Protein Binding Assay Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Plasma Protein Binding Assay Market Size by Region (2018-2029)
1.4 Global Plasma Protein Binding Assay Historic Market Size by Region (2018-2023)
1.5 Global Plasma Protein Binding Assay Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Plasma Protein Binding Assay Market Size (2018-2029)
1.6.1 North America Plasma Protein Binding Assay Market Size (2018-2029)
1.6.2 Europe Plasma Protein Binding Assay Market Size (2018-2029)
1.6.3 Asia-Pacific Plasma Protein Binding Assay Market Size (2018-2029)
1.6.4 Latin America Plasma Protein Binding Assay Market Size (2018-2029)
1.6.5 Middle East & Africa Plasma Protein Binding Assay Market Size (2018-2029)
2 Plasma Protein Binding Assay Market by Type
2.1 Introduction
2.1.1 Equillibrium Dialysis
2.1.2 Ultrafiltration
2.1.3 Ultracentrifugation
2.1.4 Gel Filtration Chromatography
2.2 Global Plasma Protein Binding Assay Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Plasma Protein Binding Assay Historic Market Size by Type (2018-2023)
2.2.2 Global Plasma Protein Binding Assay Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Plasma Protein Binding Assay Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Plasma Protein Binding Assay Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Plasma Protein Binding Assay Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Plasma Protein Binding Assay Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Plasma Protein Binding Assay Revenue Breakdown by Type (2018-2029)
3 Plasma Protein Binding Assay Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical & Biotechnology Companies
3.1.2 Contract Research Organization
3.2 Global Plasma Protein Binding Assay Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Plasma Protein Binding Assay Historic Market Size by Application (2018-2023)
3.2.2 Global Plasma Protein Binding Assay Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Plasma Protein Binding Assay Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Plasma Protein Binding Assay Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Plasma Protein Binding Assay Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Plasma Protein Binding Assay Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Plasma Protein Binding Assay Revenue Breakdown by Application (2018-2029)
4 Plasma Protein Binding Assay Competition Analysis by Players
4.1 Global Plasma Protein Binding Assay Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Plasma Protein Binding Assay as of 2022)
4.3 Date of Key Players Enter into Plasma Protein Binding Assay Market
4.4 Global Top Players Plasma Protein Binding Assay Headquarters and Area Served
4.5 Key Players Plasma Protein Binding Assay Product Solution and Service
4.6 Competitive Status
4.6.1 Plasma Protein Binding Assay Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 3B Pharmaceuticals
5.1.1 3B Pharmaceuticals Profile
5.1.2 3B Pharmaceuticals Main Business
5.1.3 3B Pharmaceuticals Plasma Protein Binding Assay Products, Services and Solutions
5.1.4 3B Pharmaceuticals Plasma Protein Binding Assay Revenue (US$ Million) & (2018-2023)
5.1.5 3B Pharmaceuticals Recent Developments
5.2 Absorption Systems
5.2.1 Absorption Systems Profile
5.2.2 Absorption Systems Main Business
5.2.3 Absorption Systems Plasma Protein Binding Assay Products, Services and Solutions
5.2.4 Absorption Systems Plasma Protein Binding Assay Revenue (US$ Million) & (2018-2023)
5.2.5 Absorption Systems Recent Developments
5.3 Admecell
5.3.1 Admecell Profile
5.3.2 Admecell Main Business
5.3.3 Admecell Plasma Protein Binding Assay Products, Services and Solutions
5.3.4 Admecell Plasma Protein Binding Assay Revenue (US$ Million) & (2018-2023)
5.3.5 Biotium Recent Developments
5.4 Biotium
5.4.1 Biotium Profile
5.4.2 Biotium Main Business
5.4.3 Biotium Plasma Protein Binding Assay Products, Services and Solutions
5.4.4 Biotium Plasma Protein Binding Assay Revenue (US$ Million) & (2018-2023)
5.4.5 Biotium Recent Developments
5.5 Danaher Corporation
5.5.1 Danaher Corporation Profile
5.5.2 Danaher Corporation Main Business
5.5.3 Danaher Corporation Plasma Protein Binding Assay Products, Services and Solutions
5.5.4 Danaher Corporation Plasma Protein Binding Assay Revenue (US$ Million) & (2018-2023)
5.5.5 Danaher Corporation Recent Developments
5.6 Eurofins Scientific
5.6.1 Eurofins Scientific Profile
5.6.2 Eurofins Scientific Main Business
5.6.3 Eurofins Scientific Plasma Protein Binding Assay Products, Services and Solutions
5.6.4 Eurofins Scientific Plasma Protein Binding Assay Revenue (US$ Million) & (2018-2023)
5.6.5 Eurofins Scientific Recent Developments
5.7 GE Healthcare
5.7.1 GE Healthcare Profile
5.7.2 GE Healthcare Main Business
5.7.3 GE Healthcare Plasma Protein Binding Assay Products, Services and Solutions
5.7.4 GE Healthcare Plasma Protein Binding Assay Revenue (US$ Million) & (2018-2023)
5.7.5 GE Healthcare Recent Developments
5.8 Htdialysis
5.8.1 Htdialysis Profile
5.8.2 Htdialysis Main Business
5.8.3 Htdialysis Plasma Protein Binding Assay Products, Services and Solutions
5.8.4 Htdialysis Plasma Protein Binding Assay Revenue (US$ Million) & (2018-2023)
5.8.5 Htdialysis Recent Developments
5.9 Merck
5.9.1 Merck Profile
5.9.2 Merck Main Business
5.9.3 Merck Plasma Protein Binding Assay Products, Services and Solutions
5.9.4 Merck Plasma Protein Binding Assay Revenue (US$ Million) & (2018-2023)
5.9.5 Merck Recent Developments
5.10 Sovicell GmbH
5.10.1 Sovicell GmbH Profile
5.10.2 Sovicell GmbH Main Business
5.10.3 Sovicell GmbH Plasma Protein Binding Assay Products, Services and Solutions
5.10.4 Sovicell GmbH Plasma Protein Binding Assay Revenue (US$ Million) & (2018-2023)
5.10.5 Sovicell GmbH Recent Developments
5.11 Thermo Fisher Scientific
5.11.1 Thermo Fisher Scientific Profile
5.11.2 Thermo Fisher Scientific Main Business
5.11.3 Thermo Fisher Scientific Plasma Protein Binding Assay Products, Services and Solutions
5.11.4 Thermo Fisher Scientific Plasma Protein Binding Assay Revenue (US$ Million) & (2018-2023)
5.11.5 Thermo Fisher Scientific Recent Developments
6 North America
6.1 North America Plasma Protein Binding Assay Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Plasma Protein Binding Assay Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Plasma Protein Binding Assay Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Plasma Protein Binding Assay Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Plasma Protein Binding Assay Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Plasma Protein Binding Assay Market Dynamics
11.1 Plasma Protein Binding Assay Industry Trends
11.2 Plasma Protein Binding Assay Market Drivers
11.3 Plasma Protein Binding Assay Market Challenges
11.4 Plasma Protein Binding Assay Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
